Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
22
Treatment with the ELIOS System
Elios Vision Clinical Site
Glendale, Arizona, United States
Elios Vision Clinical Site
Rock Island, Illinois, United States
Elios Vision Clinical Site
St Louis, Missouri, United States
Elios Vision Clinical Site
Oklahoma City, Oklahoma, United States
Proportion of subjects who achieve a decrease in mean diurnal IOP (DIOP) from baseline of at least 20% on the same or fewer medications
Proportion of subjects who achieve a decrease in mean diurnal IOP (DIOP) from baseline of at least 20% on the same or fewer medications
Time frame: 12 Months
Mean Change in DIOP from baseline on the same or fewer medications
Mean Change in DIOP from baseline on the same or fewer medications
Time frame: 12 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Elios Vision Clinical Site
El Paso, Texas, United States
Elios Vision Clinical Site
Kenosha, Wisconsin, United States